Financial comparisons Akeso, Inc.

Equities

Delayed Hong Kong S.E. Other stock markets 07:06:10 12/03/2026 am IST			5-day change	1st Jan Change
116.70 ^HKD	+1.57%		+12.65%	+1.68%

05/03	Nomura Adjusts Akeso's Price Target to HK$112.73 From HK$120.64, Keeps at Neutral	MT
05/03	Akeso, Inc. Presents Long-Term Phase II Results For Cadonilimab In Recurrent Or Metastatic Cervical Cancer	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (N-1)	Net Margin (N-1)	EBIT Margin (N-1)	ROE (N-1)	ROA (N-1)	Leverage (N-1)
AKESO, INC.	29Cr	-24.22%	-26.28%	-8.94%	-4.69%	-2.82x
ARGENX SE	221.87Cr	36.99%	-0.96%	2.26%	2.02%	818.71x
WUXI APPTEC CO., LTD.	537.62Cr	24.08%	29.51%	16.78%	12.27%	-0.97x
INSMED INCORPORATED	61Cr	-210.54%	-205.59%	-249.28%	-	0.72x
BIONTECH SE	336.96Cr	-39.59%	-48.95%	-4.4%	-5.08%	11x
WUXI BIOLOGICS (CAYMAN) INC.	255.86Cr	17.97%	25.37%	11.65%	8.43%	-0.66x
GENMAB A/S	369.4Cr	25.89%	28.63%	20.56%	12.29%	-1.54x
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	26Cr	-13.8%	-7.18%	-9.46%	-9.11%	18.95x
EXELIXIS, INC.	232.01Cr	33.73%	37.59%	35.53%	27.02%	-1.18x
MADRIGAL PHARMACEUTICALS, INC.	96Cr	-30.08%	-31.31%	-42.49%	-	2.15x
IMMUNITYBIO, INC.	11Cr	-310.18%	-226%	-	-	-
ARROWHEAD PHARMACEUTICALS, INC.	83Cr	-0.2%	11.86%	-0.5%	-	-6.61x
PHARMAESSENTIA CORPORATION	50Cr	32.27%	31.52%	16.33%	13.74%	-4x
REMEGEN CO., LTD.	24Cr	-85.53%	-78.53%	-54.06%	-26.62%	-1.54x
CYTOKINETICS, INCORPORATED	8.8Cr	-891.6%	-695.44%	-	-54.35%	0.77x
Average	156.15Cr	-95.65%	-77.05%	-20.46%	-2.19%	59.50x
Weighted average by Cap.	220.91Cr	-54.97%	-50.7%	-28.73%	2.09%	148.02x